INTRA CELLULAR THERAPIES INC's ticker is ITCI and the CUSIP is 46116X101. A total of 241 filers reported holding INTRA CELLULAR THERAPIES INC in Q1 2022. The put-call ratio across all filers is 0.55 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $131 | +35.1% | 2,518 | +64.9% | 0.10% | +33.8% |
| Q2 2023 | $97 | -26.5% | 1,527 | -37.2% | 0.07% | -35.7% |
| Q1 2023 | $132 | -40.5% | 2,433 | -42.0% | 0.12% | +26.4% |
| Q4 2022 | $222 | -99.7% | 4,194 | +122.1% | 0.09% | +16.7% |
| Q3 2022 | $88,000 | +700.0% | 1,888 | +898.9% | 0.08% | +766.7% |
| Q2 2022 | $11,000 | +1000.0% | 189 | +1475.0% | 0.01% | +800.0% |
| Q1 2022 | $1,000 | 0.0% | 12 | -20.0% | 0.00% | 0.0% |
| Q4 2021 | $1,000 | – | 15 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sarissa Capital Management LP | 675,000 | $26,203,000 | 7.44% |
| EcoR1 Capital, LLC | 244,950 | $9,509,000 | 3.75% |
| Redmile Group, LLC | 971,565 | $37,716,000 | 3.60% |
| Ghost Tree Capital, LLC | 120,000 | $4,658,000 | 1.34% |
| SENZAR ASSET MANAGEMENT, LLC | 144,624 | $5,614,304,000 | 1.22% |
| GREAT POINT PARTNERS LLC | 100,000 | $3,882,000 | 1.11% |
| BB BIOTECH AG | 700,000 | $27,174,000 | 1.07% |
| Rhenman & Partners Asset Management AB | 115,000 | $4,464,000 | 0.79% |
| Lisanti Capital Growth, LLC | 12,260 | $476,000 | 0.72% |
| Rock Springs Capital Management LP | 190,000 | $7,376,000 | 0.55% |